Sideris Pharmaceuticals
1 clinical trials · Sponsor
◉ Watch Sideris Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia (NCT02274233) | Sideris Pharmaceuticals | 2014-10-01 |
Track Sideris Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.